Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes

Synthesis and in vitro evaluation of fluorescent and magnetic nanoparticles functionalized with a cell penetrating peptide for cancer theranosis

(2017) Emiliana Perillo et al.   JOURNAL OF COLLOID AND INTERFACE SCIENCE

HER2-positive breast cancer

(2017) Sibylle Loibl et al.   LANCET

Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy

(2017) Eameema Muntimadugu et al.   PHARMACOLOGICAL RESEARCH

Antibody fragments as nanoparticle targeting ligands: a step in the right direction

(2017) Daniel A. Richards et al.   Chemical Science

To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?

(2016) F. Danhier   JOURNAL OF CONTROLLED RELEASE

Ligand-targeted theranostic nanomedicines against cancer

(2016) Virginia J. Yao et al.   JOURNAL OF CONTROLLED RELEASE

In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody

(2016) Ning Ding et al.   MOLECULAR IMAGING AND BIOLOGY

Use of Single-Chain Antibody Derivatives for Targeted Drug Delivery

(2016) Yaghoub Safdari et al.   MOLECULAR MEDICINE

Covalent conjugation of cysteine-engineered scFv to PEGylated magnetic nanoprobes for immunotargeting of breast cancer cells

(2016) Christophe Alric et al.   RSC Advances

Positron Emission Tomography Based Elucidation of the Enhanced Permeability and Retention Effect in Dogs with Cancer Using Copper-64 Liposomes

(2015) Anders E. Hansen et al.   ACS Nano

Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity

(2015) Hiroshi Maeda   ADVANCED DRUG DELIVERY REVIEWS

In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles

(2015) Hamed Arami et al.   CHEMICAL SOCIETY REVIEWS

A method to confer Protein L binding ability to any antibody fragment

(2015) Zineb Lakhrif et al.   mAbs

Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging

(2015) Kengo Kanazaki et al.   Nanomedicine-Nanotechnology Biology and Medicine

ScFv-Decorated PEG-PLA-Based Nanoparticles for Enhanced siRNA Delivery to Her2+Breast Cancer

(2014) Shuang Dou et al.   Advanced Healthcare Materials

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

(2013) Nicolas Bertrand et al.   ADVANCED DRUG DELIVERY REVIEWS

The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo

(2012) Hiroshi Maeda et al.   ADVANCED DRUG DELIVERY REVIEWS

Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy

(2012) Mi Kyung Yu et al.   Theranostics

Surface Engineering of Iron Oxide Nanoparticles for Targeted Cancer Therapy

(2011) Forrest M. Kievit et al.   ACCOUNTS OF CHEMICAL RESEARCH

Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress

(2011) Twan Lammers et al.   JOURNAL OF CONTROLLED RELEASE

Endocytosis of nanomedicines

(2010) Gaurav Sahay et al.   JOURNAL OF CONTROLLED RELEASE

Nanoparticles functionalised with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells

(2009) Kim L. Vigor et al.   BIOMATERIALS

Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging

(2008) Tapan K. Jain et al.   BIOMATERIALS

Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats

(2008) Michelle Longmire et al.   Nanomedicine

The development of stable aqueous suspensions of PEGylated SPIONs for biomedical applications

(2008) K Hervé et al.   NANOTECHNOLOGY